SOLIGENIX, INC. Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount
SOLIGENIX, INC. (SNGX) reported Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount of 7.69 million shares for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount · last filed 2026-08-07
- SOLIGENIX, INC. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2026-03-31 was 7.69M shares, a 353.07% increase year-over-year.
- SOLIGENIX, INC. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2025-03-31 was 1.70M shares, a 111.94% increase year-over-year.
- SOLIGENIX, INC. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2024-03-31 was 800.92K shares, a 136.53% increase year-over-year.
- SOLIGENIX, INC. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2023-03-31 was 338.62K shares, a 8.23% increase year-over-year.
- SOLIGENIX, INC. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2025 was 7.69M shares, a 273.77% increase from fiscal 2024.
- SOLIGENIX, INC. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2024 was 2.06M shares, a 178.38% increase from fiscal 2023.
- SOLIGENIX, INC. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2023 was 739.22K shares, a 107.91% increase from fiscal 2022.
- SOLIGENIX, INC. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2022 was 355.54K shares, a 32.34% decline from fiscal 2021.
| Period end | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3 month as first filed | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 6 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 6 month as first filed | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 9 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 9 month as first filed | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 12 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | 7.69M shares 10-Q · filed 2026-08-07 | |||||||
| 2026-03-31 | 7.69M shares 10-Q · filed 2026-05-08 | |||||||
| 2025-12-31 | 7.69M shares 10-K · filed 2026-03-31 | |||||||
| 2025-09-30 | 7.32M shares 10-Q · filed 2025-11-07 | |||||||
| 2025-06-30 | 1.77M shares 10-Q · filed 2026-08-07 | |||||||
| 2025-03-31 | 1.70M shares 10-Q · filed 2026-05-08 | |||||||
| 2024-12-31 | 2.06M shares 10-K · filed 2026-03-31 | |||||||
| 2024-09-30 | 1.60M shares 10-Q · filed 2025-11-07 | |||||||
| 2024-06-30 | 1.31M shares 10-Q · filed 2025-08-14 | |||||||
| 2024-03-31 | 800.92K shares 10-Q · filed 2025-05-09 | 9.45M shares 10-Q · filed 2024-05-10 | ||||||
| 2023-12-31 | 739.22K shares 10-K · filed 2025-03-21 | 9.56M shares 10-K · filed 2024-03-15 | ||||||
| 2023-09-30 | 1.59M shares 10-Q · filed 2024-11-08 | 8.90M shares 10-Q · filed 2023-11-13 | ||||||
| 2023-06-30 | 588.56K shares 10-Q · filed 2024-08-09 | 8.88M shares 10-Q · filed 2023-08-21 | ||||||
| 2023-03-31 | 338.62K shares 10-Q · filed 2024-05-10 | |||||||
| 2022-12-31 | 355.54K shares 10-K · filed 2024-03-15 | |||||||
| 2022-09-30 | 312.10K shares 10-Q · filed 2023-11-13 | 4.68M shares 10-Q · filed 2022-11-10 | ||||||
| 2022-06-30 | 312.89K shares 10-Q · filed 2023-08-21 | 4.69M shares 10-Q · filed 2022-08-12 | ||||||
| 2022-03-31 | 312.88K shares 10-Q · filed 2023-05-15 | 4.69M shares 10-Q · filed 2022-05-13 | ||||||
| 2021-12-31 | 525.47K shares 10-K · filed 2023-03-31 | 5.44M shares 10-K · filed 2022-03-29 | ||||||
| 2021-09-30 | 12.61M shares 10-Q · filed 2022-11-10 | 7.73M shares 10-Q · filed 2021-11-12 | ||||||
| 2021-06-30 | 10.11M shares 10-Q · filed 2022-08-12 | 7.67M shares 10-Q · filed 2021-08-13 | ||||||
| 2021-03-31 | 10.16M shares 10-Q · filed 2022-05-13 | 7.73M shares 10-Q · filed 2021-05-18 | ||||||
| 2020-12-31 | 7.67M shares 10-K · filed 2022-03-29 | |||||||
| 2020-09-30 | 7.44M shares 10-Q · filed 2021-11-12 | |||||||
| 2020-06-30 | 7.39M shares 10-Q · filed 2021-08-13 | |||||||
| 2020-03-31 | 7.45M shares 10-Q · filed 2021-05-18 | |||||||
| 2019-12-31 | 7.70M shares 10-K · filed 2021-03-30 | |||||||
| 2019-09-30 | 7.63M shares 10-Q · filed 2020-11-12 | |||||||
| 2019-06-30 | 7.40M shares 10-Q · filed 2019-08-13 | 7.40M shares 10-Q · filed 2020-08-14 | ||||||
| 2019-03-31 | 7.39M shares 10-Q · filed 2020-05-15 | |||||||
| 2018-12-31 | 7.33M shares 10-K · filed 2020-03-30 | |||||||
| 2018-09-30 | 7.09M shares 10-Q · filed 2018-11-09 | 7.09M shares 10-Q · filed 2019-11-12 | ||||||
| 2018-06-30 | 3.34M shares 10-Q · filed 2019-08-13 | 3.34M shares 10-Q · filed 2019-08-13 | ||||||
| 2018-03-31 | 3.36M shares 10-Q · filed 2019-05-14 | |||||||
| 2017-12-31 | 3.36M shares 10-K · filed 2019-03-26 | |||||||
| 2017-09-30 | 3.11M shares 10-Q · filed 2018-11-09 | 3.11M shares 10-Q · filed 2018-11-09 | ||||||
| 2017-06-30 | 3.12M shares 10-Q · filed 2018-08-08 | 3.12M shares 10-Q · filed 2018-08-08 | ||||||
| 2017-03-31 | 3.32M shares 10-Q · filed 2018-05-11 | |||||||
| 2016-12-31 | 3.18M shares 10-K · filed 2018-03-15 | |||||||
| 2016-09-30 | 792.37K shares 10-Q · filed 2017-11-06 | 488.67K shares 10-Q · filed 2017-11-06 | ||||||
| 2016-06-30 | 500.58K shares 10-Q · filed 2017-08-11 | 5.03M shares 10-Q · filed 2016-08-11 | 500.58K shares 10-Q · filed 2017-08-11 | 5.03M shares 10-Q · filed 2016-08-11 | ||||
| 2016-03-31 | 471.40K shares 10-Q · filed 2017-05-11 | 4.71M shares 10-Q · filed 2016-05-12 | ||||||
| 2015-12-31 | 769.47K shares 10-K · filed 2017-03-27 | 7.69M shares 10-K · filed 2016-03-24 | ||||||
| 2015-09-30 | 418.99K shares 10-Q · filed 2016-11-10 | 4.19M shares 10-Q · filed 2015-11-12 | 722.69K shares 10-Q · filed 2016-11-10 | 7.23M shares 10-Q · filed 2015-11-12 | ||||
| 2015-06-30 | 7.29M shares 10-Q · filed 2016-08-11 | 7.29M shares 10-Q · filed 2016-08-11 | ||||||
| 2015-03-31 | 8.36M shares 10-Q · filed 2016-05-12 | |||||||
| 2014-12-31 | 5.03M shares 10-K · filed 2016-03-24 | |||||||
| 2014-09-30 | 8.30M shares 10-Q · filed 2015-11-12 | 8.30M shares 10-Q · filed 2015-11-12 | ||||||
| 2014-06-30 | 8.92M shares 10-Q · filed 2015-08-12 | 8.92M shares 10-Q · filed 2015-08-12 | ||||||
| 2014-03-31 | 8.94M shares 10-Q · filed 2015-05-14 | |||||||
| 2013-12-31 | 10.21M shares 10-K · filed 2015-03-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Imunon, Inc. (IMNN) | United States | $0.008B | -0.56 |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |
| Traws Pharma, Inc. (TRAW) | United States | $0.009B | -0.58 |
| Alzamend Neuro, Inc. (ALZN) | United States | $0.009B | |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| FibroBiologics, Inc. (FBLG) | United States | $0.009B | -0.27 |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |